Pentoxifylline decreases allodynia and hyperalgesia in a rat model of neuropathic pain

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 4, 2011, Pages 306-311

  Vakili, A ^a   Shirvanian, M J ^a   Safakhah, H A ^a   Rashidy Pour, A ^a  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic Constriction Injury (CCI); Thermal and mechanical allodynia; Thermal hyperalgesia

Indexed keywords

PENTOXIFYLLINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; HYPERALGESIA; MALE; MECHANICAL ALLODYNIA; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; RAT; SCIATIC NERVE; SYSTEMIC THERAPY; THERMAL ALLODYNIA; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80054827175     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol, 2001; 429:23-37.
2. Colombo E, Francisconi S, Faravelli L, Izzo E, Pevarello P. Ion channel blockers for the treatment of neuropathic pain. Future Med Chem, 2010; 2:803-42.
3. Hoot MR, Sim-Selley LJ, Selley DE, Scoggins KL, Dewey WL. Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus. Brain Res, 2011; 1406:1-7.
4. Zhou HY, Chen SR, Pan HL. Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain. Expert Rev Clin Pharmacol, 2011; 4:379-388.
5. Berger JV, Knaepen L, Janssen SP, Jaken RJ, Marcus MA, Joosten EA, Deumens R. Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Res Rev, 2011; 67: 282-310.
6. Sorkin LS, Doom CM. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J. Peripher Nerv Syst, 2000; 5:96-100.
7. Vale ML, Benevides VM, Sachs D, Brito GA, da Rocha FA, Poole S, Ferreira SH, Cunha FQ, Ribeiro RA. Antihyperalgesic effect of Pentoxifylline on experimental inflammatory pain, Br. J. Pharmacol, 2004; 143: 833-844.
8. Xie W, Luo S, Xuan H, Chou C, Song G, Lv R, Jin Y, Li W, Xu J. Betamethasone affects cerebral expressions of NF-kappaB and cytokines that correlate with pain behavior in a rat model of neuropathy. Ann Clin Lab Sci, 2006; 36:39-46.
9. Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol, 2003; 30: 2563-71
10. Sweitzer SM, Schubert P, DeLeo JA. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J. Pharmacol Exp Ther, 2001; 297: 1210-1217.
11. Raghavendra V, Tanga FY, DeLeo JA. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology, 2004; 29: 327-334.
12. Dorazil-Dudzik M, Mika J, Schafer MK, Li Y, Obara I, Wordliczek J, Przewlocka B. The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw. Anesth Analg, 2004; 98: 1566-1573.
13. Liu J, Feng X, Yu M, Xie W, Zhao X, Li W, Guan R, Xu J. Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain. Neurosci Lett, 2007; 412:268-72
14. Vakili A, Mojarad S, Akhavan MM, Rashidy-pour A. Pentoxifylline attenuates TNF-α protein levels and brain edema following temporary focal cerebral ischemia in rats. Brain Res, 2011; 1377: 119-125.
15. Schwarz T, Schwarz A, Krone C, Luger TA. Pentoxifylline suppresses allergic patch test reactions in humans. Arch Dermatol, 1993; 129:513-4.
16. Huizinga TW, Dijkmans BA, van der Velde EA, van de Pouw Kraan TC, Verweij CL, Breedveld FC. An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Ann Rheum Dis, 1996; 55:833-6.
17. Sampaio EP, Moraes MO, Nery JA, Santos AR, Matos HC, Sarno EN. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol, 1998; 111:300-8.
18. Vakili A and Zahedi khorasani M. Post-ischemic treatment of pentoxifyline reduces cortical not striatal infarct volume in transient model of focal cerebral ischemia in rat. Brain Res, 2007 1144: 186-191.
19. Sirin BH, Yilik L, Coskun E, Ortac R, Sirin H. Pentoxifylline reduces injury of the brain in transient ischaemia. Acta Cardiol, 1998; 53: 89-95.
20. Wordliczek J, Szczepanik A. M, Banach M, Turchan J, Zembala M, Siedlar M, Przewlocki R, Serednicki W, Przewlocka, B. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci, 2000, 66: 1155-1164.
21. Mika J, Osikowicz M, Makuch W, Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol, 2007; 560: 142-9.
22. Bennett GJ, Xie YK. A peripheral mononeuropathie in rat that produces disorders of pain sensation like those seen in man. Pain, 1988; 33: 87-107.
23. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods, 1994; 53: 55-63.
24. Liu J, Li W, Zhu J, Zhang J, Feng X, Guan R, Xu J. The effect of pentoxifylline on existing hypersensitivity in a rat model of neuropathy. Anesth Analg, 2008; 106:650-3
25. Kumazawa T. Primitivism and plasticity of pain--implication of polymodal receptors. Neurosci Res, 1998; 32: 9-31.
26. Sugimoto T, Bennett GJ, Kajander KC. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine. Pain, 1990; 42:205-13.
27. Empl M, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, Steck AJ. TNF-alpha expression in painful and nonpainful neuropathies. Neurology, 2001; 56: 1371-137.
28. Ignatowski TA, Covey WC, Knight PR, Severin CM, Nickola TJ, Spengler RN. Brain-derived TNFalpha mediates neuropathic pain. Brain Res, 1999; 841: 70-77.
29. Tegeder I, Niederberger E, Schmidt R, Kunz S, Gühring H, Ritzeler O, Michaelis M, Geisslinger G. Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci, 2004; 24:1637-45.
30. Lundblad R, Ekstrøm P, Giercksky KE. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Shock, 1995; 3:210-5.